Skip to main content

Table 5 Recommendation summary - diagnostic tests in newly diagnosed CKD

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

 

CEBAM

ACP

HAS

KDIGO

KHA-CARI

BCMA

UMHS

VA-DoD

NICE

2012

2013

2013

2013

2013

2014

2014

2014

2015

Diagnostic Tests in newly diagnosed CKD

clinical blood tests

 blood pressure

    

    

 serum creatinine

  

    

 (e)GFR (creatinine)

*

 

 

 blood count

  

 

    

 serum urea

  

i

 

    

 serum uric acid

  

      

 serum albumin

  

i

 

    

 serum electrolytes

  

 

    

 serum glucose

  

 

    

 lipids

  

 

    

 serum cystatin C

   

i

     

 eGFR (cystatin C)

        

i

 clearance

   

i

     

 HbA1c

         

 serum calcium

  

 

i

    

 serum phosphate

    

i

    

 serum phosphorus

  

i

      

 serum PTH

  

 

i

    

 serum 25-hydroxy-Vitamin D

  

 

i

    

 iron

    

i

    

 serum electrophoresis

  

i

 

i

    

 ANA

  

i

 

i

    

 anti-ENA

    

i

    

 complement

  

i

 

i

    

 Hepatitis-B serology

    

i

    

 Hepatitis-C serology

    

i

    

 HIV-serology

    

i

    

 anti-GBM

  

i

 

i

    

 ANCA

  

i

 

i

    

 inulin

        

i

51Cr-EDTA

        

i

125I-iothalamate

        

i

 iohexol

        

i

urine tests

 albuminuria

  

i

 

 proteinuria - reagent strips

        

- ***

 urine albumin-creatinin-ratio (ACR)

▪**

   

i

  

n

 urine protein-creatinin ratio (PCR)

▪**

       

i

 urine leucocytes

  

      

 hematuria

  

(▪) ****

    

unclear*****

 urine microscopy

    

   

(−)

 24 h urine

  

i

      

 urine electophoresis

    

i

    

imaging

 renal ultrasound

i

 

 

 

i

i

 bladder ultrasound

  

i

      

 MRI

         

 CT

         

 Angiography

         

 renal artery doppler

  

i

   

i

  

invasive

 kidney biopsy

  

i

      
  1. ▪ recommendation, − negative recommendation, i: when indicated, *implicitly mentioned, **ACR or PCR, ***unless able to detect microalbuminuria, ****no explicitly formulated recommendation, but mentioned in background and a flow diagram, *****opportunistic detection
  2. ANA anti-nuclear antibodies, anti-ENA anti extractable nuclear antibodies, ANCA anti-neutrophil cytoplasmic antibodies, anti-GBM anti-glomerular basement membrane antibodies, eGFR estimated glomerular filtration rate, PTH parathyroid hormone
  3. American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)